Fantastic documents with great discussions on systems of care and importance of diligent assessment to maintain program for ECPR in refractory arrrst

Join us in one hour #TCT2025 @crfheart on the other part that matters as a practicing IC - coding, reimbursement, and surviving financially, practically, and logistically in the modern cath lab @SCAI at TCT @JDawnAbbott1 @mszerlip @AGoldsweig @triciarawh

Radial to Peripheral: Iliac CTO 🦵🏼🦵🏼Bilateral disease ⤴️Attempted retro cross via fem 😵‍💫To tortuous 💪🏼Plan B: R2P 119cm 🦷Crossed and flossed 💋Bilateral Kissing Covered Stents “A failure to plan is a plan to fail” - B. Frank #Cardiology #IRAD #Vasctwitter #CardioX #PAD

Long "slender" sheaths can reduce the risk of access site crossover when starting #RadialFirst @nyugrossman @nyulangone

Some great talks at #CShockLATAM25 on acute & chronic RV shock incl this by @SripalBangalore. Highlights include CPES score to predict normotensive shock, risk strat in PE (high risk PE mortality>>STEMI mortality) & the spiral fr ⬆️ RV afterload to obstructive #CardiogenicShock

💡 AI is reshaping cardiovascular care—but are we ready? Key findings from our recent analysis of FDA-approved AI/ML cardiovascular devices (1995–2024), @JACCJournals- ✨ 209 cardiovascular devices cleared, with 85% approved since 2015. 📄 Full study:

🎥 Fellowship Recruitment Spotlight 🎥 Our fellows Dr. Tinatin Saralidze and Dr. Sanjay Sivalokanathan take just two minutes to share what makes training at MountSinai Morningside so unique! Hear directly from those living the experience — why they chose our program, and why

Results of the SYMPHONY PE IDE trial presented as a late breaker @PERTConsortium and simultaneously published online @CircIntv. A new era in mechanical thrombectomy? @jameshorowitzmd @SVRaoMD @vivianbishay @drandrewsharp @glennfishman https://t.co/VBSOEs91hJ

Our Division is incredibly proud of our @UpstateNews Department of Medicine Chair and Division of Cardiology member, Dr. @CynthiaTaub for leading the document, Guidelines for the Standardization of Adult Echocardiography Reporting: Recommendations From the @ASE360. The guideline

The MISSION Act has given US veterans more freedom to access healthcare but at the cost of potentially worse CV care when compared with VA facilities. Increasing access is an admirable goal, but may lead to unintended results, according to study co-author @jaygirimd.

Now in @JACCJournals, we cover the economics of transcatheter interventions. This includes: 1) mechanics of facility & doc payment 2) rapidly evolving CV financial landscape 3) novel research on hospital margins 4) future health econ policy shifts https://t.co/e9lm0IM1EA

Thrilled to share that Mount Sinai Morningside has been ranked in top‑20 hospitals in the United States for Cardiology & Heart Surgery- U.S. News & World Report 2025‑26! 🫀 We are proud to deliver leading cardiovascular care at MSMW and contributing to this national recognition!

Confounders, Effect Modifiers, and Mediators: Dealing With “Third Variables” in Cardiovascular Epidemiology: @CircAHA 🥸 Epi 101 from PhD times; nice work from the TIMI group. 😱 Few definitions below; always good to understand the difference between these 👇👇👇

🎥#SCAIRDN Program Chair @TaiKobayashiMD, discusses program highlights and what to look forward to in the course on June 6 in Houston. Register today to learn how to build an optimal #RDN program and improve hypertension treatment for your patients.🏥 🔗 https://t.co/FXEeCkCziv

🃏 We shared some classic dad jokes with #SCAI2025 attendees last week—now it’s your turn! Got a favorite #InterventionalCardiology joke? Drop it in the comments! 💬💫 @DougDrachmanMD @CardioBox @AGoldsweig

🫁We are kicking off our #SCAI2025 half-day workshop on the treatment of #PulmonaryEmbolism now! #PE

Proximal pulmonary artery occlusion treated by balloon pulmonary angioplasty #BPA in a non-surgical patient. Celebrating 150 CTEPH cases in past 12 months @HenryFordHealth @HFHCardioFellow @SCAI @phaware @PERTConsortium

Mangesh will be applying for IM residency #Match2026 He is interested in cardiology and he has been presenting his original work in almost all major CV conferences #CardioTwitter. Very talented and hard working kid. Programs will be lucky to have him.

Here’s my guide to navigate the #ACC25 trials, coming this weekend and featured in many journals with a (very) high impact factor. 1. WARRIOR = Intensive medical therapy in women with ANOCA/INOCA 2. STRIDE = Semaglutide in type 2 diabetes and peripheral artery disease 3. API-CAT

Another #Endo trick. If using Perclose and unsure of closure. Stick in 0.014 wire and put in a 4F micro access catheter and sinch down. Still allows you to take a final angio to ensure artery still open. @VascularSVS @AMPSymposium @FutureVascSurgn #medtwitter @EVToday #vascular